12-06-2013, 12:22 AM
Cell Based Assays Congress 2014 Europe
Organisers: Paradigm Global Events
Dates: February 27th-28th 2014
Location: Holiday Inn Bloomsbury, London, UK
Website: http://www.paradigmglobalevents.com/even...13-europe/
The website gives all the necessary information on abstract submission, conference agenda, hotel, exhibitions and other important facts.
Who should attend?
Presidents, Chief Executives, Chief Scientific Officers, Chief Operating Officers, Vice Presidents, Senior Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Principal Investigators, Managers, Project /Team Leaders in:
• High-Throughput / High – Content Screening Operations
• GPCR / Kinases / Molecular Pharmacology
• Stem Cell Technologies & Platforms
• Bioanalytical Development
• Toxicology and Safety Testing
• Pharmacovigilance and Safety Testing
• In Vitro Sciences
• Drug Delivery
• Drug Discovery / Validation
• Drug Development
• Antibody Discovery
• ADMET
• Pre-clinical Development
• Medical Chemistry
• Compound Profiling
• Cellular Imaging
• Lead Generation
• Pharmacodynamics
• Pharmacokinetics
• External/Contract Research
• Medical Chemistry
• Chemistry and Bioapplications
• Global Research and Development
• Business Development
• Investment and Venture Capital
• Neuroscience – Preclinical & Biomarkers
• Neurodegenerative and Neurological Diseases
Purpose of the conference
This conference aims to explore the latest thinking and techniques in the field of cell-based assays. Companies have become more aware of the utility of these types of assays in reducing the number of clinical candidates that do not progress through the pipeline, as the assays demonstrably prove leads have a clinical effect. The event will cover a multitude of topics including: ion channel assays, 3D assays, GPCR, as well as stem cell assays. It will also address subjects such as: post-analytics, quality control, and outsourcing. The conference also offers networking opportunities with professionals in the field.
Key speakers
• Professor Paul French – Photonics Group, Physics Department, Imperial College London
• Dr. David Hay – Principal Investigator, MRC Centre for Regenerative Medicine, University of Edinburgh
• Dr Sheraz Gul, CChem MRSC, CSi, European ScreeningPort GmbH
• Grant Cameron, PhD – RAFT Development Director, Tap Biosystems
• Dr. Anthony Davies, Director of the High Content Facility, Institute of Molecular Medicine, Trinity College Dublin
• Dr. Olivier Pardo, Team Leader, Lecturer, Division Cancer, Imperial College London
• Farnaz Fallah-Arani, Dept. of Pharmacology at UCB Celltech, Slough, UK
• Michael Dabrowski, PhD, CEO Pelago Biosciences
• Dr. Rozbeh Jafari, PhD, Post Doc, Karolinska Institute
Organisers: Paradigm Global Events
Dates: February 27th-28th 2014
Location: Holiday Inn Bloomsbury, London, UK
Website: http://www.paradigmglobalevents.com/even...13-europe/
The website gives all the necessary information on abstract submission, conference agenda, hotel, exhibitions and other important facts.
Who should attend?
Presidents, Chief Executives, Chief Scientific Officers, Chief Operating Officers, Vice Presidents, Senior Vice Presidents, Heads, Senior Directors, Directors, Clinicians, Principal Scientists, Principal Investigators, Managers, Project /Team Leaders in:
• High-Throughput / High – Content Screening Operations
• GPCR / Kinases / Molecular Pharmacology
• Stem Cell Technologies & Platforms
• Bioanalytical Development
• Toxicology and Safety Testing
• Pharmacovigilance and Safety Testing
• In Vitro Sciences
• Drug Delivery
• Drug Discovery / Validation
• Drug Development
• Antibody Discovery
• ADMET
• Pre-clinical Development
• Medical Chemistry
• Compound Profiling
• Cellular Imaging
• Lead Generation
• Pharmacodynamics
• Pharmacokinetics
• External/Contract Research
• Medical Chemistry
• Chemistry and Bioapplications
• Global Research and Development
• Business Development
• Investment and Venture Capital
• Neuroscience – Preclinical & Biomarkers
• Neurodegenerative and Neurological Diseases
Purpose of the conference
This conference aims to explore the latest thinking and techniques in the field of cell-based assays. Companies have become more aware of the utility of these types of assays in reducing the number of clinical candidates that do not progress through the pipeline, as the assays demonstrably prove leads have a clinical effect. The event will cover a multitude of topics including: ion channel assays, 3D assays, GPCR, as well as stem cell assays. It will also address subjects such as: post-analytics, quality control, and outsourcing. The conference also offers networking opportunities with professionals in the field.
Key speakers
• Professor Paul French – Photonics Group, Physics Department, Imperial College London
• Dr. David Hay – Principal Investigator, MRC Centre for Regenerative Medicine, University of Edinburgh
• Dr Sheraz Gul, CChem MRSC, CSi, European ScreeningPort GmbH
• Grant Cameron, PhD – RAFT Development Director, Tap Biosystems
• Dr. Anthony Davies, Director of the High Content Facility, Institute of Molecular Medicine, Trinity College Dublin
• Dr. Olivier Pardo, Team Leader, Lecturer, Division Cancer, Imperial College London
• Farnaz Fallah-Arani, Dept. of Pharmacology at UCB Celltech, Slough, UK
• Michael Dabrowski, PhD, CEO Pelago Biosciences
• Dr. Rozbeh Jafari, PhD, Post Doc, Karolinska Institute